Assessing whether there is a cancer premium for the value of a statistical life

Health Economics (United Kingdom)

Volumn 23, Issue 4, 2014, Pages 384-396

  Viscusi, W Kip ^a   Huber, Joel ^b   Bell, Jason ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

cancer; risk; stated preference; value of a statistical life (VSL)

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER RISK; ETHNICITY; FATALITY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; PATIENT PREFERENCE; PRIORITY JOURNAL; PROBABILITY; QUALITY OF LIFE; RISK REDUCTION; SAMPLE SIZE; UNITED KINGDOM; UNITED STATES; VALUE OF A STATISTICAL LIFE; ECONOMICS; EPIDEMIOLOGY; FEMALE; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTOR; SOCIOECONOMICS;

FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROBABILITY; RISK FACTORS; RISK REDUCTION BEHAVIOR; UNITED STATES; VALUE OF LIFE;

EID: 84904242736     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.2919     Document Type: Article

References (27)

1. Adamowicz W, Dupont D, Krupnick A, Zhang J,. 2011. Valuation of Cancer and Microbial Disease Risk Reductions in Municipal Drinking Water: An Analysis of Risk Context Using Multiple Valuation Methods. Journal of Environmental Economics and Management 61 (2): 213-226.
2. Benjamin DK, Dougan WR, Buschema D,. 2001. Individuals' Estimates of the Risks of Death: Part II-New Evidence. Journal of Risk and Uncertainty 22 (1): 35-51.
3. Burnett JK, Hahn RW,. 2001. A Costly Benefit: Economic Analysis Does Not Support EPA's New Arsenic Rule. Regulation 24 (3): 44-49.
4. Chen C-J, Wang C-J,. 1990. Ecological Correlation between Arsenic Level in Well Water and Age-adjusted Mortality from Malignant Neoplasms. Cancer Research 50: 5470-5474.
5. Chilton S, Jones-Lee M, Kiraly F, Metcalf H, Pang W,. 2006. Dread Risks. Journal of Risk and Uncertainty 33 (3): 165-182.
6. Coaster M, Rogers BP, Jones OD, Viscusi WK, Merkle KL, Zald DH, Gore JC,. 2011. Variables Influencing the Neural Correlates of Perceived Risk of Physical Harm. Cognitive, Affective, & Behavioral Neuroscience 11 (4): 494-507.
7. Eckel CC, Grossman PJ,. 2008. Differences in the Economic Decisions of Men and Women: Experimental Evidence. In, Plott CR, Smith VL, eds., Handbook of Experimental Economics Results. Elsevier: New York.
8. Hammitt JK, Haninger K,. 2010. Valuing Fatal Risks to Children and Adults: Effects of Disease, Latency, and Risk Aversion. Journal of Risk and Uncertainty 40 (1): 57-83.
9. Hammitt JK, Liu J-T,. 2004. Effects of Disease Type and Latency on the Value of Mortality Risk, Journal of Risk and Uncertainty 28 (1): 73-95.
10. Kniesner TK, Viscusi WK, Woock C, Ziliak JP,. 2012. The Value of Statistical Life: Evidence from Panel Data, The Review of Economics and Statistics 94 (1): 74-87.
11. Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Goldman DP, Philipson TJ,. 2010. An Economic Evaluation of the War on Cancer. Journal of Health Economics 29 (3): 333-346.
12. Lang H-C, Chang K, Ying Y-H,. 2012. Quality of Life, Treatments, and Patients' Willingness to Pay for a Complete Remission of Cervical Cancer in Taiwan. Health Economics 21 (10): 1217-1233.
13. Magat WA, Viscusi WK, Huber J,. 1996. A Reference Lottery Metric for Valuing Health. Management Science 42 (8): 1118-1130.
14. Magat WA, Huber J, Viscusi WK,. 2000. An Iterative Choice Approach to Valuing Clean Lakes, Rivers and Streams. Journal of Risk and Uncertainty 21 (1): 7-43.
15. Mason H, Jones-Lee M, Donaldson C,. 2009. Modelling the Monetary Value of a QALY: A New Approach Based on UK Data. Health Economics, 18 (8): 933-950.
16. National Research Council (US), Subcommittee on Arsenic in Drinking Water. 2001. Arsenic in Drinking Water: 2001 Update. National Academy Press; Washington, D.C. 64.
17. Smith RD,. 2008. Contingent Valuation in Health Care: Does It Matter How the 'Good' Is Described? Health Economics 17 (5): 607-617.
18. Tversky A, Kahneman DJ,. 1992. Advances in Prospect Theory: Cumulative Representation of Uncertainty. Journal of Risk and Uncertainty 5 (4): 297-323.
19. UK Health and Safety Executive. 2001. Reducing Risks, Protecting People: HSE's Decision-Making Process.
20. UK HM Treasury. 2011. The Green Book: Appraisal and Evaluation in Central Government: Treasury Guidance. London: TSO.
21. US Department of Housing and Urban Development. 2011. American Housing Survey for the United States, 2009, Series H-150/09. Current Housing Reports. Washington, D.C.: US Government Printing Office.
22. US Environmental Protection Agency. 2010. Valuing Mortality Risk Reductions for Environmental Policy: A White Paper. SAB Review Draft.
23. Van Houtven G, Sullivan MB, Dockins C,. 2008. Cancer Premiums and Latency Effects: A Risk Tradeoff Approach for Valuing Reductions in Fatal Cancer Risks. Journal of Risk and Uncertainty 36 (2): 179-199.
24. Viscusi WK, Aldy JE,. 2003. The Value of a Statistical Life: A Critical Review of Market Estimates throughout the World. Journal of Risk and Uncertainty 27 (1): 5-76.
25. Viscusi WK, Magat W, Huber J,. 1987. An Investigation of the Rationality of Consumer Valuations of Multiple Health Risks. The RAND Journal of Economics 18 (4): 465-479.
26. Wescoat JL, Jr., Headington L, Theobald R,. 2007. Water and Poverty in the United States. Geoforum 38 (5): 801-814.
27. Wooldridge JM,. 2010. Econometric Analysis of Cross Section and Panel Data. MIT Press: Cambridge.